To amend the Controlled Substances Act to make marijuana accessible for use by qualified marijuana researchers for medical purposes, and for other purposes.
The bill’s titles are written by its sponsor.
Sponsor and status
116th Congress (2019–2021)
This bill was introduced in a previous session of Congress and was passed by the House on December 9, 2020 but was never passed by the Senate.
Although this bill was not enacted, its provisions could have become law by being included in another bill. It is common for legislative text to be introduced concurrently in multiple bills (called companion bills), re-introduced in subsequent sessions of Congress in new bills, or added to larger bills (sometimes called omnibus bills).
21 Cosponsors (12 Republicans, 9 Democrats)
Position statements
What legislators are saying
“Griffith-Backed Medical Marijuana Research Act Passes House”
—
Rep. Morgan Griffith [R-VA9]
(Co-sponsor)
on Dec 9, 2020
“Smucker Cosponsors Medical Marijuana Research Act”
—
Rep. Lloyd Smucker [R-PA11]
(Co-sponsor)
on Jan 8, 2020
“E&C Republican Leaders' Statement on House Passage of Health Bills”
—
Rep. Michael Burgess [R-TX26]
on Dec 9, 2020
More statements at ProPublica Represent...
What stakeholders are saying
History
|
Jul 17, 2019
|
|
Introduced
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber. |
|
Jan 15, 2020
|
|
Considered by Health
A committee held a hearing or business meeting about the bill.
|
|
Sep 9, 2020
|
|
Ordered Reported
A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee. |
|
Sep 25, 2020
|
|
Text Published
Updated bill text was published as of Preprint (Suspension). |
|
Dec 4, 2020
|
|
Text Published
Updated bill text was published as of Preprint (Suspension). |
|
Dec 7, 2020
|
|
Reported by House Committee on Energy and Commerce
A committee issued a report on the bill, which often provides helpful explanatory background on the issue addressed by the bill and the bill's intentions. |
|
Dec 9, 2020
|
|
Passed House (Senate next)
The bill was passed in a vote in the House. It goes to the Senate next. The vote was by voice vote so no record of individual votes was made. |
|
Apr 4, 2022
|
|
Reintroduced Bill —
Passed House (Senate next)
This activity took place on a related bill, H.R. 5657. |
H.R. 3797 (116th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
Bills numbers restart every two years. That means there are other bills with the number H.R. 3797. This is the one from the 116th Congress.
This bill was introduced in the 116th Congress, which met from Jan 3, 2019 to Jan 3, 2021. Legislation not passed by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
“H.R. 3797 — 116th Congress: Medical Marijuana Research Act.” www.GovTrack.us. 2019. August 13, 2022 <https://www.govtrack.us/congress/bills/116/hr3797>
- show another citation format:
- APA
- Blue Book
- Wikipedia Template
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.
